A. Illaro

Computerized physician order entry‐based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project

J. Crespo, B. Sampedro, C. Hernández-López, 2014, Hepatology.

Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: A retrospective study of 100 patients in daily practice

P. Coto-Segura, J. Santos-Juanes, A. Illaro, 2015, The Journal of dermatological treatment.

Treating multidrug‐resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID‐19 pandemic

M. González-Gay, A. Illaro, M. G. González López, 2020, Dermatologic therapy.

Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

E. Cordero, J. Aguado, M. Fernández-Ruiz, 2022, Transplantation.

First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trial.

M. Ochagavía, J. Llorca, A. Illaro, 2015, The Journal of antimicrobial chemotherapy.

Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies.

P. Martín-Dávila, A. Illaro, M. Valerio, 2024, Transplantation.